GO
Loading...

Health Care

More

  • GlaxoSmithKline Fires R&D Boss in Data Scandal Tuesday, 11 Jun 2013 | 6:35 PM ET
    A worker in vaccine production at drugmaker GlaxoSmithKline in Saint-Amand-les-Eaux, France.

    GlaxoSmithKline fired the head of its R&D operations in China after a tipster spurred an inquiry that found "misrepresented" data were used in a multiple sclerosis study.

  • Plan-B for All—No Age Limits on Morning-After Pill Tuesday, 11 Jun 2013 | 10:17 AM ET

    Obama administration to scrap age restrictions on the sale of morning-after pills, making the emergency contraception available to women and girls of any age without a prescription.

  • Universal Health CEO: Obamacare=Healthy Earnings Tuesday, 11 Jun 2013 | 3:17 PM ET
    Alan Miller, CEO, Universal Health Services

    Obamacare's implementation may look like a "train wreck," but Universal Health Services CEO Alan Miller says his $7 billion hospital company is well-positioned for the changes.

  • Susan Komen CEO Pay Draws Fire as Donations Drop Monday, 10 Jun 2013 | 12:45 PM ET
    Nancy Brinker, Founder, Susan G. Komen for the Cure.

    Months after the Komen Foundation's decision to cut Planned Parenthood funding sparked widespread backlash, the group's CEO still holds her position and received a large raise.

  • Experts Mull New Rules of Road for Kid Transplants Monday, 10 Jun 2013 | 11:36 AM ET

    Transplant experts will meet to decide whether and how to change the rules for children, after the parents of two youngsters successfully sued to get restrictions temporarily lifted.

  • AstraZeneca Buys Pearl for Up to $1.15 Billion Monday, 10 Jun 2013 | 5:37 AM ET
    Respiratory therapists assess, treat, and care for patients with breathing disorders.

    AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion, as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making.

  • The Worst Allergy Season Ever     Friday, 7 Jun 2013 | 2:45 PM ET

    Allergy season has been getting longer every year for 15 years, with Dr. Michael Foggs of American College of Allergy, Asthma and Immunology; and Stephen Brozak, WBB Securities, discusses the big money in the allergy business.

  • Cramer: Jazz Up the Portfolio with This Stock? Friday, 7 Jun 2013 | 6:25 PM ET

    With its cheap multiple and serious upside potential, Cramer thinks this stock could give your portfolio a kick.

  • Obama Address Health Care & Privacy Concerns     Friday, 7 Jun 2013 | 12:25 PM ET

    CNBC's John Harwood provides perspective on President Obama's address on health care, invasion of privacy concerns, and his meeting later today with China's President Xi.

  • Pres. Obama Defends Data Collection Programs     Friday, 7 Jun 2013 | 12:15 PM ET

    President Obama answers questions about privacy concerns surrounding the NSA's collection of telephone records and monitoring of Internet activity. "Congress is continually briefed" on how these activities are conducted, Obama says.

  • Pres. Obama Speaks on Affordable Care Act     Friday, 7 Jun 2013 | 12:00 PM ET

    President Obama explains the "two main things Americans need to know" about the new legislation on health care. The President outlines how competition will provide an incentive to keep health care costs down, and cover millions of people who currently don't have insurance coverage.

  • Awaiting President Obama's Statement     Friday, 7 Jun 2013 | 11:50 AM ET

    CNBC's John Harwood provides a preview of the President's address on the benefits of the Affordable Care Act. He also addresses the NSA phone records issue.

  • Obama to Address Health Care, Jobs & Privacy     Friday, 7 Jun 2013 | 11:04 AM ET

    CNBC's John Harwood presents a preview of President Obama's statement on the Affordable Care Act, and likely comments on this morning's better-than-expected jobs number, as pressure mounts for him to address NSA privacy concerns ahead of his meeting later today with China's President Xi.

  • Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, coming back for the third time after just 7.5 percent of shareholders accepted the last offer.

  • Dirty Endoscopes Raise Risk for Patients Friday, 7 Jun 2013 | 10:23 AM ET

    A new study released Friday discovered that an average of 15 percent of flexible endoscopes used to examine GI tracts and colons at five hospitals were dirty.

  • Novartis Bringing Innovation to China: CEO     Thursday, 6 Jun 2013 | 9:45 PM ET

    Joseph Jimenez, CEO of Novartis, says the pharmaceutical company is investing heavily to introduce new drugs in China as the spotlight shifts from infectious to chronic disease.

  • Aetna CEO on the Next Four Years of Health Care     Wednesday, 13 Feb 2013 | 8:42 AM ET

    Mark Bertolini, Chairman, Chief Executive Officer and President of Aetna, weighs in on the President's comments last night about the state of the nation's health care system, and how to bring down health care costs.

  • A Healthier Deficit?     Tuesday, 12 Feb 2013 | 1:41 PM ET

    CNBC's Eamon Javers reports the CBO projects 2020 Medicare/Medicaid spending to be $200 billion, which is 15 percent less than projected.

  • Slower Growth of Health Costs Eases US Deficit Tuesday, 12 Feb 2013 | 8:33 AM ET

    A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.

  • An Alternative to Obamcare     Monday, 11 Feb 2013 | 7:38 PM ET

    Discussing America's health care system, with Dr. Benjamin Carson, Johns Hopkins Pediatric Neurosurgery Director Also, Igor Volsky, ThinkProgress.com and serial misinformer Betsy McCaughey, weigh in.

Contact Health Care

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More